Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect on glucose control of 3 different AZD1656
dosing regimens with placebo in Japanese type 2 diabetes mellitus (T2DM) patients, as
evaluated by the change in HbA1c from baseline to the end of treatment at 4 months.